Evidence map›Paper›PMID 23254112›Full record

ReviewRetrovirology2012

Host restriction factors in retroviral infection: promises in virus-host interaction.

Yong-Hui Zheng, Kuan-Teh Jeang, Kenzo Tokunaga

Abstract readReview
In one paragraph

Review in Retrovirology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Effect of Opioid Use on Immune Activation and HIV Persistence on ART.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yong-Hui ZhengDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, USA. zhengyo@msu.edu
Kuan-Teh Jeang
Kenzo Tokunaga

Funding

Molecular Mechanisms Of Human Immunodeficiency Virus Trans-regulatory ProteinsZIAAI000547 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JEANG, KUAN-TEH · 2009 to 2013
$5.9M
Actions of Vif and APOBEC3 proteins in HIV-1 ReplicationR01AI063944 · NIAID · MICHIGAN STATE UNIVERSITY · PI ZHENG, YONG-HUI · 2006 to 2010
$1.9M
Mechanism of APOBEC3-Mediated Innate Immunity to HIV-1K02AI080225 · NIAID · MICHIGAN STATE UNIVERSITY · PI ZHENG, YONG-HUI · 2008 to 2012
$618k
VprR21AI106477 · NIAID · MICHIGAN STATE UNIVERSITY · PI ZHENG, YONG-HUI · 2013 to 2014
$408k
Actions of Vif and APOBEC3 Proteins in HIV-1 ReplicationR56AI063944 · NIAID · MICHIGAN STATE UNIVERSITY · PI ZHENG, YONG-HUI · 2011 to 2011
$362k
Intramural NIH HHSNIAID NIH HHS AI063944NIAID NIH HHS AI080225NIAID NIH HHS R21 AI106477
6 · The paper itself

Abstract

Retroviruses have an intricate life cycle. There is much to be learned from studying retrovirus-host interactions. Among retroviruses, the primate lentiviruses have one of the more complex genome structures with three categories of viral genes: structural, regulatory, and accessory genes. Over time, we have gained increasing understanding of the lentivirus life cycle from studying host factors that support virus replication. Similarly, studies on host restriction factors that inhibit viral replication have also made significant contributions to our knowledge. Here, we review recent progress on the rapidly growing field of restriction factors, focusing on the antiretroviral activities of APOBEC3G, TRIM5, tetherin, SAMHD1, MOV10, and cellular microRNAs (miRNAs), and the counter-activities of Vif, Vpu, Vpr, Vpx, and Nef.

Indexed as

Host-Pathogen InteractionsAnimalsHumansProteinsRetroviridaeRetroviridae InfectionsVirus ReplicationProteins

Identifiers

PMID23254112
PMCPMC3549941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.